Skip to main content

Research Repository

Advanced Search

All Outputs (20)

Quantifying the prevalence and impact of risk factors that might explain why women with type 2 diabetes have higher mortality rate than men of similar age using the retrospective data from Salford Hospital, England (2023)
Presentation / Conference
Whyte, M., Laing, I., Meza-Torres, B., Robinson, A., Fryer, A., & Heald, A. (2023, April). Quantifying the prevalence and impact of risk factors that might explain why women with type 2 diabetes have higher mortality rate than men of similar age using the retrospective data from Salford Hospital, England. Presented at Diabetes UK Professional Conference 2023, Exhibition Centre Liverpool, Liverpool, England, UK

Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a 'Nearly Post COVID-19' World (2022)
Presentation / Conference
Heald, A., Holland, D., Duff, C. J., Scargill, J., Hanna, F., & Fryer, A. (2022, November). Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a 'Nearly Post COVID-19' World. Poster presented at Society for Endocrinology BES 2022, Harrogate, United Kingdom

Background: We previously showed that in first 6 months of the UK Covid-19(C19) pandemic >6.6million HbA1c tests were missed, including 1.4million in people with diabetes(DM). Furthermore, C19 more significantly impacts people with DM / socioeconomic... Read More about Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a 'Nearly Post COVID-19' World.

Speed of recovery of testing for management of diabetes in the aftermath of COVID-19 is slower in areas of greater social deprivation: findings from a UK study (2022)
Presentation / Conference
Holland, D., Heald, A., Hanna, F., Wu, P., & Fry, A. (2022, September). Speed of recovery of testing for management of diabetes in the aftermath of COVID-19 is slower in areas of greater social deprivation: findings from a UK study. Poster presented at 58 th EASD Annual Meeting of the European Association for the Study of Diabetes, Stockholm, Sweden

Background and aims: We have previously shown that, during the first 6 months of the UK COVID-19-associated lockdown, >6.6M HbA1c tests were missed/delayed, including 1.41M missed/delayed in people with diabetes (0.51M in those with suboptimal contro... Read More about Speed of recovery of testing for management of diabetes in the aftermath of COVID-19 is slower in areas of greater social deprivation: findings from a UK study.

Variability in test interval is linked to glycated haemoglobin (HbA1c) trajectory over time in people with diabetes (2022)
Presentation / Conference
Fryer, A., Holland, D., Stedman, M., Duff, C., Green, L., Scargill, J., …Heald, A. (2022, March). Variability in test interval is linked to glycated haemoglobin (HbA1c) trajectory over time in people with diabetes. Poster presented at Diabetes UK Professional Conference 2022, Hybrid/Online

Introduction: Frequency of HbA1c testing links to outcome in terms of HbA1c control in diabetes. The influence of the variability of test-retest interval on HbA1c change needs to be determined. Methods: HbA1c results were collected from laboratory... Read More about Variability in test interval is linked to glycated haemoglobin (HbA1c) trajectory over time in people with diabetes.

Patients with type 1 diabetes self-reported views on their own condition management reveal links to potential improved outcomes and numbers of potential areas for service improvement (2020)
Presentation / Conference
Stedman, M., Fryer, A., Duff, C., Gadsby, R., Rea, R., Grady, K., …Heald, A. (2020, September). Patients with type 1 diabetes self-reported views on their own condition management reveal links to potential improved outcomes and numbers of potential areas for service improvement. Poster presented at Diabetes UK Professional Conference 2020

Aims Patient's own self-management of their type 1 diabetes has moved forward in many areas over the last 40 years. An examination of the observed variation within patients own treatment patterns might reveal valuable insights. Methods An electron... Read More about Patients with type 1 diabetes self-reported views on their own condition management reveal links to potential improved outcomes and numbers of potential areas for service improvement.

More frequent lithium testing associates with lower hospital admission rate for bipolar disorder - what this tells us about GP practice engagement with this group (2019)
Presentation / Conference
Holland, D., Healy, A., Stedman, M., Duff, C., Fryer, A., Yung, A., & Bailey, S. (2019, April). More frequent lithium testing associates with lower hospital admission rate for bipolar disorder - what this tells us about GP practice engagement with this group. Presented at 27th European Congress of Psychiatry, Warsaw, Poland

Background and aims.– Lithium treatment is a cornerstone of bipolar affective disorder management. We determined how frequency of lithium level checks at GP (family) practice level relates to psychiatric admission rate for bipolar affective disord... Read More about More frequent lithium testing associates with lower hospital admission rate for bipolar disorder - what this tells us about GP practice engagement with this group.

Differences in activity from Hospital Episode Statistics (HES) for patients with Type 2 diabetes and patients without diabetes linked at GP Practice level (GPP) to levels of glycaemic control as measured by glycated haemoglobin (HbA1c) taken from National Diabetes Audit (NDA) allowing for age, social deprivation, gender and ethnicity of both populations (2019)
Presentation / Conference
Stedman, M., Heald, A., Davies, M., Fryer, A., Lunt, M., Livingstone, M., …Andersen, S. (2019, March). Differences in activity from Hospital Episode Statistics (HES) for patients with Type 2 diabetes and patients without diabetes linked at GP Practice level (GPP) to levels of glycaemic control as measured by glycated haemoglobin (HbA1c) taken from National Diabetes Audit (NDA) allowing for age, social deprivation, gender and ethnicity of both populations. Paper presented at Diabetes UK Professional Conference 2019, ACC Liverpool, Liverpool, UK

Aims: To compare associated hospital activity between patients with Type 2 diabetes and patients without diabetes and consider the impact of differing levels of glycaemic control on this difference, allowing for variation in local demographics. Me... Read More about Differences in activity from Hospital Episode Statistics (HES) for patients with Type 2 diabetes and patients without diabetes linked at GP Practice level (GPP) to levels of glycaemic control as measured by glycated haemoglobin (HbA1c) taken from National Diabetes Audit (NDA) allowing for age, social deprivation, gender and ethnicity of both populations.

Practice based analysis of Type 2 diabetes shows that patients’ own perceptions of support within primary care as per GP Patient Survey (GPPS) are as important as medication and services in improving Target Glycaemic Control (TGC-%HbA1c results ≤58mmol/mol) and reducing high glycaemic risk (HGR-%HbA1c results >86mmol/mol) as reported in the National Diabetes Audit (NDA) (2019)
Presentation / Conference
Heald, A., Stedman, M., Fryer, A., Gadsby, R., Ollier, W., Bailey, S., …Moreno, G. (2019, March). Practice based analysis of Type 2 diabetes shows that patients’ own perceptions of support within primary care as per GP Patient Survey (GPPS) are as important as medication and services in improving Target Glycaemic Control (TGC-%HbA1c results ≤58mmol/mol) and reducing high glycaemic risk (HGR-%HbA1c results >86mmol/mol) as reported in the National Diabetes Audit (NDA). Poster presented at Diabetes UK Professional Conference 2019, ACC Liverpool, Liverpool, UK

Aims: To evaluate the link between patients’ own perception of support within primary care and % patients in TGC and HGR groups, while allowing for local medication, services and demographics. Method: National Diabetes Audit (NDA) 2016–17 publishe... Read More about Practice based analysis of Type 2 diabetes shows that patients’ own perceptions of support within primary care as per GP Patient Survey (GPPS) are as important as medication and services in improving Target Glycaemic Control (TGC-%HbA1c results ≤58mmol/mol) and reducing high glycaemic risk (HGR-%HbA1c results >86mmol/mol) as reported in the National Diabetes Audit (NDA).

Gestational diabetes mellitus: are mothers being followed-up? A retrospective study (2018)
Presentation / Conference
Ward, R., Hanna, F. W., Shelley-Hitchen, A., Hodgson, E., Heald, A., Fryer, A. A., & Duff, C. J. (2018, June). Gestational diabetes mellitus: are mothers being followed-up? A retrospective study

Background Women with gestational diabetes (GDM) have an elevated risk of developing type 2 diabetes (T2DM). NICE Guidance recommends women who develop GDM are screened 6 weeks post-partum and annually thereafter. Aim To evaluate conformity to gui... Read More about Gestational diabetes mellitus: are mothers being followed-up? A retrospective study.

Real-world evidence confirms that increased blood glucose monitoring strip (BGMS) accuracy reduces glycated haemoglobin (HbA1c) variance (2018)
Presentation / Conference
HEALD, A., Livingston, M., Fryer, A., Cortes, M., Gadsby, R., Ollier, W., …Craig, J. (2018, March). Real-world evidence confirms that increased blood glucose monitoring strip (BGMS) accuracy reduces glycated haemoglobin (HbA1c) variance. Poster presented at Diabetes UK Professional Conference 2018, London ExCeL, London, UK

Aim: An in silico study has reported a link between less accurate BGMS and poorer glycaemic control, leading to significant differences in both hyper- and hypoglycaemic events. Our aim was to see if we could detect this effect of BGMS accuracy on gly... Read More about Real-world evidence confirms that increased blood glucose monitoring strip (BGMS) accuracy reduces glycated haemoglobin (HbA1c) variance.

Real-world data analysis of general practice prescribing (GPP) to highlight the growing challenges in application of appropriate medication for Type 2 diabetes (2018)
Presentation / Conference
HEALD, A., Livingston, M., Fryer, A., Cortes, M., Bien, Z., Gadsby, R., …Young, R. (2018, March). Real-world data analysis of general practice prescribing (GPP) to highlight the growing challenges in application of appropriate medication for Type 2 diabetes. Poster presented at Diabetes UK Professional Conference 2018, London ExCeL, London, UK

Objective: GP apply the wide variety of Type 2 diabetes medications at different rates. Our aim was to see if there are lessons to be learnt from analysing in detail these variations. Methods: England GPP and Quality Outcome Framework data over th... Read More about Real-world data analysis of general practice prescribing (GPP) to highlight the growing challenges in application of appropriate medication for Type 2 diabetes.

High rates of diabetes found in post-partum follow up of women with gestational diabetes, but screening rates still not high enough (2017)
Presentation / Conference
Ward, R., Hanna, F., Shelley-Hitchen, A., Hodgson, E., Heald, A., Fryer, A., & Duff, C. (2017, March). High rates of diabetes found in post-partum follow up of women with gestational diabetes, but screening rates still not high enough. Paper presented at Abstracts of the Diabetes UK Professional Conference 2017, Manchester, England, UK

Background: Women diagnosed with gestational diabetes (GDM) have elevated risk of developing Type 2 diabetes. NICE recommend women who develop GDM are screened 6 weeks post-partum and annually thereafter. Aims: To (i) evaluate conformity to guidan... Read More about High rates of diabetes found in post-partum follow up of women with gestational diabetes, but screening rates still not high enough.

Timing of HbA1c pre-admission: impact on readmission and in-hospital mortality in patients with diabetes (2015)
Presentation / Conference
Arora, A., Shanmugasundaram, M., Varughese, G., Duffs, C., Fryer, A., & Nayak, A. (2015, March). Timing of HbA1c pre-admission: impact on readmission and in-hospital mortality in patients with diabetes. Poster presented at Diabetes UK Professional Conference 2015, ExCel London, UK

Aims: Association between high HbA1c and risk of all-cause hospital admissions is recognised. We aimed to investigate the impact of HbA1c screening pre-admission the time of admission, on readmission rates and in-hospital mortality. Methods: Amongst... Read More about Timing of HbA1c pre-admission: impact on readmission and in-hospital mortality in patients with diabetes.

263. Genome-Wide DNA Methylation Profiling Identifies Distinct Changes in T- and B-Cell Populations from Patients with Rheumatoid Arthritis (2014)
Presentation / Conference
Glossop, J. R., Nixon, N. B., Emes, R. D., Haworth, K. E., Packham, J. C., Dawes, P. T., …Farrell, W. E. (2014, April). 263. Genome-Wide DNA Methylation Profiling Identifies Distinct Changes in T- and B-Cell Populations from Patients with Rheumatoid Arthritis. Paper presented at Rheumatology 2014, Liverpool, UK

Background: DNA methylation is one of several epigenetic mechanisms that impacts on gene expression without underlying changes to the DNA sequence. Recent studies describe changes to the DNA methylome in RA. To date however, no systematic genome-wide... Read More about 263. Genome-Wide DNA Methylation Profiling Identifies Distinct Changes in T- and B-Cell Populations from Patients with Rheumatoid Arthritis.